Detection of intestinal pathogens through host surveillance of bacterial toxins
通过宿主细菌毒素监测来检测肠道病原体
基本信息
- 批准号:10540312
- 负责人:
- 金额:$ 3.27万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-02-01 至 2025-03-31
- 项目状态:未结题
- 来源:
- 关键词:Anti-Infective AgentsAnti-Inflammatory AgentsBacteriaBacterial ToxinsBone Marrow TransplantationCaenorhabditis elegansCell CommunicationCellsCessation of lifeCommunitiesDataDetectionDevelopmentEmbryonic DevelopmentEpithelial CellsFamilyGenesGenetic TranscriptionHNF4A geneHealthHomologous GeneHormone ReceptorHospitalizationHumanImmuneImmune responseImmunocompromised HostInfectionInflammationInflammatoryInflammatory Bowel DiseasesInflammatory ResponseInnate Immune ResponseIntestinesLigandsMetabolismModelingMolecularMonitorNatural ImmunityNuclear Hormone ReceptorsNuclear ReceptorsOrganismOxidation-ReductionPathogen detectionPathogenesisPathogenicityPatientsPattern RecognitionPattern recognition receptorPhenazinesPhysiologicalPositioning AttributeProcessProtein IsoformsPseudomonas aeruginosaPseudomonas aeruginosa infectionResearchRoleSepsisSepticemiaTestingTherapeuticToxinTranscriptional ActivationTransplant RecipientsVirulencechemotherapycommensal bacteriacommensal microbesenteric infectionenteric pathogengut colonizationgut inflammationgut microbiomehuman pathogenimmune activationimmunoregulationinsightinterestintestinal epitheliummodel organismmutantnovelpathogenpathogenic bacteriapathogenic microbeprogramsresponsetherapeutic targettranscription factor
项目摘要
PROJECT SUMMARY/ABSTRACT
Although commensal and pathogenic bacteria can be recognized by host pattern recognition receptors,
intestinal epithelial cells target protective inflammatory responses towards pathogenic organisms through
mechanisms that are incompletely understood. Additional mechanisms of pathogen sensing must exist that
allow intestinal cells to target inflammatory defenses towards bona fide pathogens during an infection, and not
harmless commensal bacteria. Pathogenic bacteria can express virulence determinants. Phenazine toxins are
a family of redox active virulence determinants that are produced by a variety of human pathogens, including P.
aeruginosa. P. aeruginosa can colonize the intestines of immunocompromised patients and cause fulminant
septicemia and subsequent death. The mechanism by which intestinal epithelial cells detect P. aeruginosa, and
whether this involves the surveillance of phenazine toxins, is not known. Nuclear hormone receptors (NHR) are
transcription factors that program adaptive host responses following recognition of specific exogenous or
endogenous ligands. In particular, HNF4⍺ is an NHR expressed in the intestine. In the model organism C.
elegans, the HNF4⍺ homolog NHR-86 is required for the transcriptional activation of innate immune effector
genes that protect against P. aeruginosa infection. The central hypothesis of this proposal is that intestinal
epithelial cells detect infection through the surveillance of pathogen-derived phenazine toxins by NHR-86/
HNF4⍺, which directly activates protective anti-pathogen defenses in the intestinal epithelium. The following
key preliminary findings support this central hypothesis: i) P. aeruginosa mutants that cannot make phenazine
toxins do not activate C. elegans innate immune defenses; ii) synthetic phenazine toxins can activate immune
genes; and iii) induction of immune genes by phenazine toxins is dependent on the expression of NHR-86/
HNF4⍺. In this proposal, Aim 1 will characterize the C. elegans immune response towards bacterial phenazine
toxins, and Aim 2 will define the role of intestinal NHR-86/HNF4⍺ in detecting P. aeruginosa infection in C.
elegans. The research proposed here will define a new concept of immune activation in intestinal epithelial
cells and will also attribute a novel role for NHRs in pathogen sensing in the intestine. Insights from these
findings may identify unexplored approaches for the development of anti-inflammatory and anti-infective
therapies.
项目摘要/摘要
尽管可以通过宿主模式识别受体识别共生和致病细菌,但
肠上皮细胞针对致病生物的受保护的炎症反应通过
未完全理解的机制。必须存在病原体传感的其他机制
允许肠细胞靶向炎症性防御剂在感染过程中,而不是
无害的共生细菌。致病细菌可以表达病毒确定。苯嗪毒素是
由多种人类病原体产生的氧化还原活性病毒决定剂家族,包括P。
铜绿。铜绿假单胞菌可以定居于免疫功能低下的患者的肠子,并引起暴发性
败血症和随后的死亡。肠上皮细胞检测铜绿假单胞菌和
这是否涉及对苯嗪毒素的监测,尚不清楚。核马酮受体(NHR)是
在识别特定外源性或
内源配体。特别是,HNF4⍺是在肠中表达的NHR。在模型生物体中。
秀丽隐杆线虫,HNF4⍺同源性NHR-86是先天免疫效应子的转录激活所必需的
预防铜绿假单胞菌感染的基因。该提议的中心假设是肠道
上皮细胞通过NHR-86/
HNF4⍺直接激活肠上皮中的保护性抗病原体防御。下列
关键初步发现支持此中心假设:i)不能使苯嗪的铜绿假单胞菌突变体
毒素不会激活秀丽隐杆线虫先天免疫防御措施; ii)合成苯丙胺毒素可以激活免疫
基因; iii)苯嗪毒素诱导免疫基因取决于NHR-86/
HNF4⍺。在此提案中,AIM 1将表征秀丽隐杆线虫对细菌苯嗪的免疫冲突
毒素和AIM 2将定义肠NHR-86/HNF4⍺在检测C.铜绿假单胞菌感染中的作用。
秀丽隐杆线。这里提出的研究将定义肠上皮中免疫激活的新概念
细胞,还将归因NHR在肠道中的病原体传感中的新作用。这些见解
调查结果可能会确定抗炎和抗感染的意外方法
疗法。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Samantha Tse其他文献
Samantha Tse的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Samantha Tse', 18)}}的其他基金
Detection of intestinal pathogens through host surveillance of bacterial toxins
通过宿主细菌毒素监测来检测肠道病原体
- 批准号:
10321888 - 财政年份:2021
- 资助金额:
$ 3.27万 - 项目类别:
相似国自然基金
靶向HDAC3/SIAH2蛋白复合物的HDAC3降解剂的作用机制、结构改造及非酶活功能介导的抗炎活性研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
卡萨烷选择性调控糖皮质激素受体GR功能的抗炎作用机制与新颖调控剂的设计与发现
- 批准号:82273824
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
靶向HDAC3/SIAH2蛋白复合物的HDAC3降解剂的作用机制、结构改造及非酶活功能介导的抗炎活性研究
- 批准号:82204218
- 批准年份:2022
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
ZAP-70选择性共价抑制剂及降解剂的设计合成和抗炎活性研究
- 批准号:82103973
- 批准年份:2021
- 资助金额:24.00 万元
- 项目类别:青年科学基金项目
ZAP-70选择性共价抑制剂及降解剂的设计合成和抗炎活性研究
- 批准号:
- 批准年份:2021
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
The joint environment and periprosthetic joint infection
关节环境与假体周围感染
- 批准号:
10744580 - 财政年份:2023
- 资助金额:
$ 3.27万 - 项目类别:
Host Directed Orynotide for MDR Gram Negative Bacterial Infections
宿主定向 Orynotide 用于治疗耐多药革兰氏阴性细菌感染
- 批准号:
10674221 - 财政年份:2023
- 资助金额:
$ 3.27万 - 项目类别:
BLRD Research Career Scientist Award Application
BLRD 研究职业科学家奖申请
- 批准号:
10594002 - 财政年份:2022
- 资助金额:
$ 3.27万 - 项目类别:
Microbiota, Probiotic and Dietary Metabolite Control of Enteric Pathogen Virulence
微生物群、益生菌和膳食代谢物对肠道病原体毒力的控制
- 批准号:
10562497 - 财政年份:2022
- 资助金额:
$ 3.27万 - 项目类别: